Adrenocortical Carcinoma Treatment Research Report: By Type (Localized Adrenocortical Carcinoma, Metastatic Adrenocortical Carcinoma), by Therapy (Radiation Therapy and Others), by End-User (Hospitals and Clinics and Others)—Forecast till 2023The global Adrenocortical Carcinoma Treatment Market is expected to grow steadily over the forecast period.It is estimated that the global Adrenocortical Carcinoma Treatment Market is expected to register a CAGR ~ 2.6 % with an anticipated market value of 678 million during the forecast period from 2018 to 2023.Adrenocortical carcinoma (ACC) is a rare and highly aggressive carcinoma.However, differentiation of benign and malignant tumor in the initial stages needs proper evaluation.These factors coupled with the lack of oncology experts may restrain the growth of the market during the forecast period.On a regional basis, the Adrenocortical Carcinoma Treatment Market in the Americas is anticipated to dominate the market during the forecast period.Moreover, higher demand for quality products and the availability of reimbursement policies are expected to contribute to the market growth in this region.Currently, the global Adrenocortical Carcinoma Treatment Market is dominated by several players.
Transverse Myelitis Research Report: By Diagnosis (Magnetic Resonance Imaging (MRI), Lumbar Puncture, Blood Tests, Others), by Treatment (Intravenous Steroids, Plasma Exchange Therapy, Antiviral Medication, Others), by End-User– Forecast Till 2023 Market Highlights Global Transverse Myelitis Treatment Market is expected to grow at a steady pace over the forecast period.It is projected to grow at a CAGR of 3.2% over the assessment period.Transverse myelitis is a neurological disorder caused due to the inflammation across both sides of one segment of the spinal cord.The causes of transverse myelitis include infections, immune system disorders, and other disorders that may damage or destroy myelin, the fatty white insulating substance covering the nerve cell fibers.The increasing prevalence of transverse myelitis ™, growing prevalence of diseases which can lead to transverse myelitis such as viral infections and some types of cancers, rising in research and development activities, and increasing expenditure on healthcare sector by the government in developed as well as developing countries is anticipated to propel the global transverse myelitis market.Regional Analysis The market in the Americas is expected to dominate the global transverse myelitis market during the forecast period owing to the presence of a well-established healthcare system, increasing healthcare expenditure, and the growing prevalence of transverse myelitis.Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to a rising number of rare diseases and continuously developing healthcare infrastructure.
Hydrophobic Interaction Chromatography Market Applications Research Report: By Product and Service (Resins, Columns, Services, Others), Sample Type (Monoclonal Antibodies, Vaccines, Others), End-User (Research & Academic Institutes) – Global Forecast Till 2023 Market Insights According to the Market Research Future Reports, the global Hydrophobic Interaction Chromatography Market is set to stagger at a CAGR OF 7.8% from the year 2018 to 2023.Hydrophobic Interaction Chromatography (HIC) is referred to as a technique which helps in separating molecules based on their hydrophobicity.This technique purifies proteins without affecting the biological activities.Therefore, the increasing demand for hydrophobic interaction chromatography resins across various end-use industries such as food and beverages and pharmaceutical are majorly expected to drive the growth of the market in the next few years.With that, the swelling scope of its usage mainly in the genetic engineering industry is another crucial factor that will support the revenue growth of the global Hydrophobic Interaction Chromatography Market Applications in the years to come.As per MRFR did the research, it mentioned that according to the European Federation of Pharmaceutical Industries and Association, in 2016, the expenditure made for research & development in the pharmaceutical industry was EUR 35000 million, while ignited the market to stagger at a considerable CAGR.The resins segment further has been segmented into bead-based resins and membrane-based resins.Whereas, HIC columns by material are further segmented into stainless steel columns and glass and plastic columns.By the mode of sample type, the market has been segmented into monoclonal antibodies, vaccines, and others.By the mode of end-user, the market has been segmented into pharmaceutical and biopharmaceutical companies, contract research organizations and contract manufacturing organizations, research and academic institutes, and others.Regional OutlookRegionally, the global hydrophobic interaction chromatography has covered significant regions such as North America, Europe, Asia-Pacific, and the Middle East and Africa.Among these, North America is expected to lead the Hydrophobic Interaction Chromatography Market Applications owing to the existence of government and public funding for protein-based research projects, rising automation of purification equipment, and growing demand for protein-based biologics.
Assisted Reproductive Technology (ART) Market Report, by Diagnosis (Ovulation Testing, Hysterosalpingography), Type (Ovulation Induction, Artificial Insemination, Surrogacy), End-User (Hospitals & Clinics, IVF Center) – Global Forecast Till 2023Market Research Future (MRFR) has announced a new release on the global Assisted Reproductive Technology (ART) Market.The report takes a close look at the historical and present trends in the global assisted reproductive technology market and provides readers with an accurate picture of the probable growth trajectory of the market over the forecast period.The segmentation and competitive landscape of the global assisted reproductive technology market are also assessed in the report to help readers understand the granular structure of the market.According to the report, the global assisted reproductive technologies market is expected to exhibit a CAGR of around 10% over the forecast period.Assisted reproductive technology includes fertility medication, in vitro fertilization, and other processes used to counter infertility in women and men and bring about fertilization.Lifestyle factors such as excessive smoking and obesity also play a part in the causation of infertility.The rising prevalence of infertility conditions around the world is set to be the prime driver for the assisted reproductive technology market, as the prevalence of the lifestyle factors contributing to infertility has risen spectacularly over the last few decades.On the other hand, the risks of assisted reproductive technology and the relatively low chances of success are likely to count against the assisted reproductive technology market over the forecast period.
Gastritis Treatment Market Information: By Diagnosis (Blood Test and Endoscopy), by Treatment (Acid Blocking Medicines and Antibiotics), by Drug Distribution Channel (Retail Pharmacy), and by End-User (Hospitals and Clinics) – Global Forecast Till 2023Market HighlightsThe Gastritis Treatment Market is expected to exhibit a robust growth rate during the forecast period.However, unaffordability and lack of advanced medical device technology in middle-income countries are likely to hamper the market growth.Regional AnalysisThe Americas is going to account for the largest share for gastritis treatment market.For instance, According to a published survey, approximately 1 in 100 is a victim of gastritis in the US.Additionally, factors such as increasing government initiatives and funding for research, development in advanced medical treatment options, and availability of favorable reimbursement policies are likely to propel the growth of gastritis treatment market in the American region.Thus, the increasing per capita income of individuals, as well as rising healthcare spending, will aid the upmarket growth of the Americas.Europe is the second market leader and holds a healthy share in the global gastritis treatment market.The European market is expected to exhibit a sturdy growth rate during the forecast period owing to the availability of advanced treatment facilities, established healthcare infrastructure along with the presence of flourishing medical device market which helps in efficient and accurate diagnosis.
Asia Pacific Pregnancy & Ovulation Testing Market Research Report: By Type (hCG Detection, Ovulation Testing), by Mode of Purchase (OTC Testing, Prescription Testing), End-User (Hospitals & Clinics, Fertility Centers, Others) – Global Forecast Till 2023Regional OutlookRegion-wise, the Asia Pacific Pregnancy and Ovulation Testing Market includes Japan, China, India, Republic of Korea, Australia, and Rest of Asia Pacific.Japan is anticipated to experience a phenomenal CAGR of 6.26% during the forecast period owing to sophisticated healthcare infrastructure and high capita per income of citizens.Rising demand for self-contained kits is expected to bolster market demand in the coming years.China and India markets can enjoy a tremendous demand over the forecast period due to high awareness levels of testing kits and numerous manufacturers launching new products annually in the region.Competitive DashboardThe market is highly fragmented and various players, at an international as well as regional levels, are imposing themselves as market influencers.Some of the key players profiled in the report include Piramal Enterprises Ltd., Mankind Pharma Ltd., Fairhaven Health, LLC, Cadila Healthcare Limited, Quidel Corporation, Geratherm Medical AG, TaiDoc Technology & Corporation, Church & Dwight Co., Inc., Gregory Pharmaceutical Holdings, Inc., and Proctor & Gamble.The Asia Pacific Pregnancy and Ovulation Testing Market is touted to touch USD 298.68 billion mark at a staggering CAGR of 6.1% during the forecast period (2018-2023), Market Research Future (MRFR) reports.The former can predict accurate results by detecting the presence of human chorionic gonadotropin (hCG) in urine, while the latter assists women by witnessing a surge in luteinizing hormone (LH) levels.Advances in home testing kits coupled with the high smartphone penetration rate have digitized test results.
TMJ Implants is a medical condition where a variety of symptoms are experienced.Such symptoms include tenderness or pain in jaws, aching facial pain, pain while chewing, and others, which is caused due to damaged caused to cartilage or when disks erode or move out out of alignment.Due to advancement in diagnostics and imaging devices, early and accurate diagnosis of teh disorders is being facilitated, which is driving the need for treatment.Imaging tests are the preferred method of diagnosis of these disorders as they deliver accurate results as compared to other methods and the segment is leading the market.By treatment, the TMJ disorders market has been segmented into medications, therapies, surgical or other procedures, alternative medicine, and others.The medications segment has been segmented into pain relievers, anti-inflammatories, tricyclic antidepressants, muscle relaxants, and others.Other therapies which help to cure this disorder include oral splints or mouth guards (occlusal appliances), physical therapy, counseling, and others.
Global Small Animal Imaging Market Research Report: By Modality (Optical Imaging System, Nuclear Imaging System, Micro MRI System, Others), By Reagent (Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Reagents, Others) – Global Forecast Till 2023Key PlayersSome of the key players in the global small animal imaging market are PerkinElmer Inc. (U.S.) Bruker Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), Aspect Imaging (Israel), LI-COR Biosciences (U.S.), Trifoil Imaging (U.S.), and Miltenyi Biotec GmbH (Germany).Market HighlightsSmall Animal Imaging Market is a technique for imaging biological and molecular processes in the small animals using imaging modalities and reagents.This technique can provide valuable information in the preclinical stage or phase I stage of clinical trials.The increase in research funding, rising demand for non invasive small animal imaging techniques, and technological developments drive the growth of global small animal imaging market.Moreover, the rising gene expression studies, increasing drug development activities and increasing government initiatives for research are likely to fuel the market growth during the forecast period.For instance, according to the Federal Funding for Biomedical and Related Life Sciences Research, 84% of the National Health Institutes (NIH) funding is distributed through 60,000 researchers to conduct various research and developments in life science sector.Additionally, according to (FASEB), NIH required a minimum of USD 35.0 billion for life science researches for the year 2017.Despite the drivers, stringent government regulations regarding animal usage in experiments, the high cost of installation and operation of imaging devices may hamper the growth of global small animal imaging market.Regional AnalysisThe Americas is likely to dominate the global small animal imaging market during the forecast period.The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and low government support.
The Multiplex Arrays Market report further includes statistics, market forecasts and revenue estimations that highlight its current and futuristic evolution and sheds light on expansion trends adopted by major industry players.Multiplex Assays Market: By Products and Services (Consumables, Instruments), by Types (Protein & Nucleic Acid Assay), by Technology (Flow Cytometry & Other Technology), by Application (Clinical Diagnostic), & End-User (Hospital)–Forecast Till 2023Multiplex Assays Market – OverviewThe uptick in demand for nanotechnology practices that can solve several genetic-related diseases has increased of late.The Multiplex Assays Market is anticipated to progress with a CAGR of 7.8% during the forecast period.Increased awareness of the benefits of multiplex assays is fuelling the growth of the market over the forecast period.The multifactorial nature of several diseases and pathological conditions such as Alzheimer and cancer are motivating the development of the market significantly.Segmental AnalysisThe multiplex assay market is segmented on the basis of types, application, products and services, technology, and enduser.By products and services, the market is segmented into instrument, consumable, and software and services.Based on types, the market is segmented into nucleic acid, protein, and cell-based multiplex assay.
Arthroscopy Instruments Market Research Report: By Products (Arthroscope, Arthroscopy Implants, Fluid Management Systems, Visualization Systems, Other), by Applications (Knee, Hip, Spine Arthroscopy, Other), By End-User – Global Forecast Till 2023Arthroscope is a trusted and well-developed form of surgery used by numerous surgeons and physicians throughout the world.This technique is usually used to treat injuries to the knee, back, elbows, knees, wrists, and ankles.According to Market Research Future (MRFR), the global Arthroscopy Instruments Market is expected to register of 6.5 % CAGR from 2018 to 2023 (forecast period).Market DynamicsA variety of factors, such as growing preference for minimally invasive procedures, increasing technological advancements, and improving the regulatory environment, are fuelling the growth of the global market for arthroscopy instruments.In addition, the rise in the incidence of sport-related musculoskeletal disorders, such as a bone tumor, rheumatoid arthritis, and osteoarthritis, is driving the development of this sector.In addition, the projection also indicates that 9.6% of men and 18.0% of women over 60 years of age have osteoarthritis.Despite these factors, the rising cost of arthroscopy instruments, the challenges of reimbursement in the medical device industry, and the weak healthcare system in low and middle-income countries may hinder the market growth.As stated in National Center for Health Statistics in the United States, nearly 650,000 arthroscopic lavage and debridement procedures are conducted annually for knee pain at an average cost of USD 5,000 each.Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/6068SegmentationThe global market for arthroscopy instrument is segmented on the basis of product, application, and end-user.Based on the product, the market is divided into arthroscopes, arthroscopic implants, fluid management systems, visualization systems, radiofrequency systems, power shavers, and others.In addition, arthroscopic implants are segmented as knee implants, hip implants, shoulder implants, and others.
Data collated by Market Research Future regarding Sleep Testing Services Market unveils a succinct analysis of the market size, regional spectrum and revenue forecast about the Endoscopy Device Market.Sleep Testing Services Market Research Report: by Diagnostic Services (Home Sleep Testing, In-Lab Sleep Testing), by Treatment Monitoring Services (Obstructive Sleep Apnea, Insomnia, Narcolepsy, Others), by End User (Hospitals, Other) – Global Forecast Till 2023Market HighlightsThe global Sleep Testing Services Market is anticipated to hold a market value of USD 5.9 billion in the year 2017 and is expected to grow at a CAGR of 13.2% during the forecast period.Sleep testing services are used to diagnose sleep disorders by recording heart rate, breathing patterns, brain waves, eye movements, leg movements, etc.Rising prevalence of sleep disorders, increasing awareness about sleep testing services and technological advancements related to sleep testing services are expected to drive the growth in the market over the forecast period.According to an article published in the Psychiatry Research magazine by Science Direct published in July 2018, global prevalence of restless leg syndrome (a sleep disorder) is 14.8%.However, high costs of the sleep testing services can restrain the market growth over the assessment period.Regional AnalysisGeographically, the Americas is expected to dominate the global market owing to the high prevalence of various sleep disorders, rising awareness about the sleep testing services.According to an article published by the National Institute of Neurological Disorders and Stroke in July 2018, 135,000 to 200,000 people in the US are affected by narcolepsy, which is a disorder that affects the sleep-wake cycle of a person.Asia-Pacific is expected to be the fastest growing market owing to the rising prevalence of sleep disorders like insomnia, restless leg syndrome, etc.
Market Research Future latest research report on Flexible And Semi-Rigid Ureteroscopy Market features a comprehensive outlook pertaining to market valuations, market share, and profit estimations.Flexible & Semi-rigid Ureteroscopy Market Research Report, by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Therapeutic Applications), End-User (Hospitals, Clinics, Ambulatory Surgical Centers)– Global Forecast Till 2023 Market Highlights The Flexible And Semi-Rigid Ureteroscopy Market is expected to witness tremendous growth owing to the rising prevalence of kidney cancer, kidney stone, and change in lifestyle.Other key factors such as the growing consumption of alcohol, change to sedentary lifestyle, increasing dehydration, and obesity are contributing towards the growth of the market.Therapeutic applications are further segmented into urinary stricture, urolithiasis, and kidney cancer.On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, ambulatory surgical centers, research centers, and others.Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/6469 Regional Analysis The Americas leads the market owing to the increasing prevalence of urolithiasis, increasing research and development programs in flexible video-ureteroscopes, and growing healthcare expenditure.According to Cancer Research UK in 2015, there were12,547 new cases of kidney cancer.
Data collated by Market Research Future regarding Obesity Treatment Market unveils a succinct analysis of the market size, regional spectrum and revenue forecast about the Endoscopy Device Market.Global Obesity Treatment Market Research Report, by Type (Inactivity, Obesity gluten, Obesity), Diagnosis (Blood Tests, Physical Examination), Treatment (Medication, Surgery, Lifestyle Changes), End-Users (Hospitals, Clinics) – Global Forecast Till 2023 Obesity is a medical condition characterized by the excessive amount of fat.It can lead to many diseases such as cardiovascular, diabetes, and others.Market Research Future (MRFR) has collected information on the causes of obesity, developments in its treatment, and medications and its prospects for the period between 2017 to 2023 (forecast period).Market ScopeThe global Obesity Treatment Market is set to expand at a CAGR of 16.7% CAGR during the forecast period.The blood tests segment is sub-segmented into cholesterol test, liver function test, thyroid test, and others.The surgery segment is sub-segmented into gastric bypass surgery, gastric sleeve, biliopancreatic diversion, laparoscopic adjustable gastric banding (LAGB), gastric sleeve, and others.End-users of the market include pharmacies, hospitals, clinics, and others.Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/5872Regional AnalysisThe Middle East & Africa (MEA), Americas, Asia Pacific (APAC), and Europe are regions which have become the focus of interest in the global obesity treatment market report.The Americas are predicted to dominate the global obesity treatment market till the end of the forecast period owing to a large obese population.
The report precisely describes key obstacles and opportunities for growth, while drawing out competitive standing of market majors, including their portfolio and growth strategies.Cervical Cancer Treatment Market Information: By Type (Squamous Cell Carcinomas, Adenocarcinomas, Adenosquamous Carcinomas), Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy), End-User (Cancer Care Centers) – Global Forecast Till 2023Cervical Cancer is a deadly disease which affects the cervix and can be prevented by regular screening tests to catch them at a preventive stage.Discernment of the presence of human papillomavirus (HPV) is the first indicator of the disease.The global cervical cancer treatment market report by Market Research Future (MRFR) contains factors and impediments which can enlighten potential investors.Market OutlookThe global Cervical Cancer Treatment Market is predicted to exhibit 6.5% CAGR from 2017 to 2023 (forecast period).Squamous cell carcinomas is expected to be the largest segment with more than 85% of cases caused by this strain of cancerous cells.By treatment, it is segmented into targeted therapy, hormone therapy, radiation therapy, chemotherapy, surgery, and others.By end-user, it is segmented into pharmacies, cancer care centers, diagnostic centers, and others.Regional Analysis Asia Pacific (APAC), the Americas, the Middle East & Africa (MEA), and Europe are regions covered in the global cervical cancer treatment market report.The Americas is expected to reign supreme till the end of the forecast period due to increased prevalence of cervical cancer and launch of effective drugs during chemotherapy.Targeted therapies and development of new imaging devices are other drivers of the regional market.